Nicolás Meyer

15.8k citations
189 papers · 4.9k · 1 hit paper · h-index 34

Impact in

  • Dermatology top 0.5%
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management

Papers in

    • Cancer Immunotherapy and Biomarkers 45
    • Cutaneous Melanoma Detection and Management 31
    • CAR-T cell therapy research 26
    • Melanoma and MAPK Pathways 25
    • Hedgehog Signaling Pathway Studies 11

Nicolás Meyer

173 papers receiving 4.8k citations

Nicolás Meyer's Hit Papers

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial 2017 · 513 citations
5130+3+6Years since publication100200300400500

Peers

Nicolás Meyer
Comparison fields: 5 of 128
  • Dermatology 708
  • Oncology 2.1k
  • Immunology 947
  • Genetics 274
  • Epidemiology 820
Replace Phyu P. Aung with:
Phyu P. Aung United States
Torben Steiniche Denmark
Jean‐Philippe Jaïs France
Thasia Woodworth United States
Semir Vranić Qatar
Andrea Abati United States
Mark W. Lingen United States
Giorgos C. Karakousis United States
Harold J. Wanebo United States
Megan L. Troxell United States
Nicolás Meyer relative to Phyu P. Aung United States Phyu P. Aung's profile →
Citations per field
00.5×2×2.6×
Phyu P. Aung · 1×
Citations per year

Countries citing papers authored by Nicolás Meyer

Since Specialization
Citations

This map shows the geographic impact of Nicolás Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Meyer more than expected).

Fields of papers citing papers by Nicolás Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Meyer. The network helps show where Nicolás Meyer may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicolás Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolás Meyer Line = papers co-authored together Nicolás Meyer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Hit paper breakdown →
2017513
2 2017287
3 2019259
4 2019219
5 2016200
6 2020193
7 2015177
8 2012160
9 2015152
10 2021131
11 201092
12 201292
13 201780
14 201678
15 200972
16 202071
17 201659
18 200658
19 201056
20 201649

About Nicolás Meyer

Nicolás Meyer is a scholar working on Oncology, Molecular Biology, Epidemiology, Immunology and Dermatology, having authored 189 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (45 papers), Cutaneous Melanoma Detection and Management (31 papers), CAR-T cell therapy research (26 papers), Melanoma and MAPK Pathways (25 papers), Nonmelanoma Skin Cancer Studies (18 papers), Immunotherapy and Immune Responses (17 papers), Brain Metastases and Treatment (12 papers) and Hedgehog Signaling Pathway Studies (11 papers). The work is most often cited by research in Dermatology (708 citations), Oncology (2.1k citations), Immunology (947 citations), Genetics (274 citations) and Epidemiology (820 citations). Nicolás Meyer has collaborated with scholars based in France, United States and Australia. Frequent co-authors include C. Paul, Laurence Lamant, Bruno Ségui, Anne Montfort, Nathalie Andrieu‐Abadie, Laurent Mortier, Céline Colacios, Thierry Levade, Jean‐Jacques Grob and V. Sibaud. Their work appears in journals such as Journal of Clinical Oncology, Journal of the European Academy of Dermatology and Venereology, Dermatology, Acta Dermato Venereologica and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact